March 6: The German drugmaker Bayer Aspirin brand recorded in 1899.

Aspirin is one of the most common drugs with an estimated 700 to 1,000 clinical trials conducted each year

It all started with the friendship between two people with intellectual curiosity and two kitchen stoves, in August 7, 1863. Friedrich Bayer, a merchant of dyes and glues, and Johann Weskott, master dyeing, began producing inks for dyeing textiles in a modest home at Wupper valley in Germany.

Willow is used as a medicine by ancient civilisations like the Sumerians and Egyptians. The Ebers papyrus, an ancient Egyptian medical text, refers to willow as an anti-inflammatory or pain reliever for non-specific aches and pains.

Ten years later, they created the department of pharmaceutical chemistry. Felix Hoffmann, a young chemist working for Bayer led the experiments to purify the synthesis of the active principle of salicylic acid, in 1897, trying to relieve rheumatic pains. On March 6, 1899, Bayer Aspirin registered the trademark in the Imperial Patent Office of Berlin.

Acetyl salicylic acid is named Aspirin by Bayer. 

The Bayer Group operates through four business units: health care, protection of crops, polymers and chemistry. The "holding" company is based in Leverkusen, North Rhine in Westphalia.

Felix Hoffmann

Acetyl salicylic acid is named Aspirin by Bayer. The letter ‘A’ stands for acetyl, “spir” is derived from the plant known as Spiraea ulmaria (meadowsweet), which yields salicin, and “in” was a common suffix used for drugs at the time of the first stable synthesis of acetylsalicylic acid.